Skip to main content
CHUC
OTC Life Sciences

Shareholders Approve Reverse Stock Split and 15M Share Equity Plan Increase

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Neutral
Importance info
8
Price
$0.245
Mkt Cap
$68.618M
52W Low
$0.077
52W High
$0.38
52W Position info
218% above low
Off High info
36% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

CHUC has more than doubled off its 52-week low of $0.077 on light trading volume (0.2× avg).

Summary

Charlie's Holdings shareholders approved a reverse stock split to facilitate uplisting and authorized an additional 15 million shares for its equity incentive plan.


Key Events · Corporate Governance and Compliance · CHUC

  • Reverse Stock Split Approved

    Shareholders granted the Board discretionary authority to effect a reverse stock split (1-for-3 to 1-for-50) within two years, a necessary step for uplisting to a national securities exchange.

  • Equity Incentive Plan Expanded

    An additional 15 million shares were approved for issuance under the 2019 Omnibus Equity Incentive Plan, representing a potential dilution of approximately 5.35% of the current market cap.

  • Directors Re-elected

    Five nominees (Ryan Stump, Scot Cohen, Jeffrey Fox, Dr. Edward Carmines, Michael King) were elected to the Board of Directors for a one-year term.

  • Auditor Ratified

    The appointment of Urish Popeck & Co., LLC as the independent registered certified public accounting firm for fiscal year 2026 was ratified by shareholders.


Analysis · CHUC · Life Sciences

Shareholders have approved a reverse stock split, granting the Board discretion to implement a ratio between 1-for-3 and 1-for-50 within two years. This is a critical step for the company's stated goal of uplisting to a national securities exchange, which could improve liquidity and institutional interest. Additionally, shareholders approved an increase of 15 million shares to the equity incentive plan, representing a significant potential dilution of approximately 5.35% of the current market capitalization for future compensation.

At the time of this filing, CHUC was trading at $0.24 on OTC in the Life Sciences sector, with a market capitalization of approximately $68.6M. The 52-week trading range was $0.08 to $0.38. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CHUC - Latest Insights

CHUC
Jul 06, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.22602
Real-time Price: $0.1611 info
Change: -$0.06492 (-29%) info
Market Cap: $45.197M info
CHUC
May 21, 2026, 6:03 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.273118
Real-time Price: $0.1611 info
Change: -$0.112018 (-41%) info
Market Cap: $45.197M info
CHUC
May 20, 2026, 6:34 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.273118
Real-time Price: $0.1611 info
Change: -$0.112018 (-41%) info
Market Cap: $45.197M info
CHUC
May 20, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.273118
Real-time Price: $0.1611 info
Change: -$0.112018 (-41%) info
Market Cap: $45.197M info
CHUC
May 18, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.250
Real-time Price: $0.1611 info
Change: -$0.0889 (-36%) info
Market Cap: $45.197M info